Lymphangioleiomyomatosis (LAM)

Explore clinical trials studying Lymphangioleiomyomatosis (LAM). Study availability and eligibility vary by location and protocol.

5 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Lymphangioleiomyomatosis (LAM) trial results

Recruiting

NCT06889168

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Columbia University Irving Medical Center New York, United States

Medical University of South Carolina Charleston, South Carolina, United States

Recruiting

NCT07304856

Conditions: Extracellular Vesicles; Generation and Function, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Pulmonology Unit ASST Santi Paolo e Carlo, Ospedale San Paolo Milan, Milano, Italy

Completed

NCT02484664

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Completed

NCT04388371

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

Completed

NCT00790400

Conditions: Angiomyolipoma, Astrocytoma, Congenital Abnormalities, +43 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Barrow Tuberous Sclerosis Center Phoenix, Arizona, United States

Massachusetts General Hospital Massachussetts General Hospita Boston, Massachusetts, United States

Minnesota Epilepsy Group Saint Paul, Minnesota, United States

View all 25 locations